BioWorld MedTech

May 19, 2016

Short-term results blur promise of healing with Abbott's Absorb stent

PARIS – The question was projected onto a big screen almost as soon as the presentations began for results from registries on the Absorb Bioresorbable Vascular Scaffold (BVS) from Abbott Vascular, based in Abbott Park, Ill. Read More

Medtronic to buy Smith & Nephew's gynecology business for $350M

Mazor shines after inking spine solutions deal with Medtronic

Fosun makes play for India firm Gland Pharma

FDA approves Genentech's immunotherapy duo Tecentriq + diagnostic for bladder cancer

CMS cites availability in DME non-bidding areas as suspension bills in play

Appointments and advancements

Product briefs

Financings

MDD's Orthopedics Extra

Today's news in brief

BioWorld

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

New mechanism of action identified for QC-6352

BioWorld Science

QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...